{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:26:07Z","timestamp":1783524367608,"version":"3.55.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.18318","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T15:34:39Z","timestamp":1601307279000},"page":"e2018318","source":"Crossref","is-referenced-by-count":22,"title":["Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018"],"prefix":"10.1001","volume":"3","author":[{"given":"Ravi B.","family":"Parikh","sequence":"first","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle W.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedha","family":"Chhatre","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Medvedeva","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Cashy","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shika","family":"Veera","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Bauml","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Fojo","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center, the College of Physicians and Surgeons at Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol S.","family":"Navathe","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Bruce","family":"Malkowicz","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronac","family":"Mamtani","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravishankar","family":"Jayadevappa","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"zoi200658r1","first-page":"479","article-title":"NCCN Guidelines Index table of contents discussion.","volume":"167","author":"Mohler","year":"2020","journal-title":"Prostate Cancer"},{"issue":"21","key":"zoi200658r2","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1001\/jama.2018.5616","article-title":"Use of conservative management for low-risk prostate cancer in the Veterans Affairs Integrated Health Care System from 2005-2015.","volume":"319","author":"Loeb","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"zoi200658r3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.2018.19941","article-title":"Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015.","volume":"321","author":"Mahal","year":"2019","journal-title":"JAMA"},{"issue":"15","key":"zoi200658r4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer.","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi200658r5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"24","key":"zoi200658r6","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","article-title":"Radical prostatectomy or watchful waiting in prostate cancer\u201329-year follow-up.","volume":"379","author":"Bill-Axelson","year":"2018","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi200658r7","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1001\/jama.2018.11716","article-title":"Prostate cancer-specific mortality across Gleason scores in black vs nonblack men.","volume":"320","author":"Mahal","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"zoi200658r8","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.urology.2014.06.064","article-title":"Active surveillance of prostate cancer in African American men.","volume":"84","author":"Silberstein","year":"2014","journal-title":"Urology"},{"key":"zoi200658r9","doi-asserted-by":"publisher","first-page":"S397","DOI":"10.21037\/tau","article-title":"Rethinking active surveillance for prostate cancer in African American men.","volume":"7","author":"Leinwand","year":"2018","journal-title":"Transl Androl Urol"},{"issue":"4","key":"zoi200658r10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/JU.0000000000000621","article-title":"African American race is not associated with risk of reclassification during active surveillance: results from the Canary Prostate Cancer Active Surveillance Study.","volume":"203","author":"Schenk","year":"2020","journal-title":"J Urol"},{"issue":"3","key":"zoi200658r11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/MOU.0000000000000039","article-title":"Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer.","volume":"24","author":"Welty","year":"2014","journal-title":"Curr Opin Urol"},{"key":"zoi200658r12","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2019.05.005","article-title":"Intensity of active surveillance and transition to treatment in men with low-risk prostate cancer.","author":"Olsson","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"zoi200658r13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of black race with prostate cancer-specific and other-cause mortality.","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7","key":"zoi200658r16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1377\/hlthaff.2014.0054","article-title":"Insights from advanced analytics at the Veterans Health Administration.","volume":"33","author":"Fihn","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"zoi200658r17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"zoi200658r18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s11606-008-0521-4","article-title":"Racial and ethnic disparities in the VA health care system: a systematic review.","volume":"23","author":"Saha","year":"2008","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi200658r20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"zoi200658r21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1472-6963-10-140","article-title":"Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality.","volume":"10","author":"Chu","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"26","key":"zoi200658r22","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible\u2014the Neighborhood Atlas.","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi200658r23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1062860617753063","article-title":"Area deprivation index predicts readmission risk at an urban teaching hospital.","volume":"33","author":"Hu","year":"2018","journal-title":"Am J Med Qual"},{"issue":"18","key":"zoi200658r25","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1002\/cncr.v125.18","article-title":"Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.","volume":"125","author":"Butler","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"zoi200658r26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.juro.2016.02.2963","article-title":"How active is active surveillance? intensity of followup during active surveillance for prostate cancer in the United States.","volume":"196","author":"Loeb","year":"2016","journal-title":"J Urol"},{"issue":"22","key":"zoi200658r27","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1001\/jama.291.22.2713","article-title":"Natural history of early, localized prostate cancer.","volume":"291","author":"Johansson","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"zoi200658r28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2012.10.002","article-title":"Natural history of early, localized prostate cancer: a final report from three decades of follow-up.","volume":"63","author":"Popiolek","year":"2013","journal-title":"Eur Urol"},{"issue":"17","key":"zoi200658r30","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1001\/jama.2019.2060","article-title":"Racial disparities in low-risk prostate cancer.","volume":"321","author":"Ehdaie","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi200658r31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semradonc.2016.08.002","article-title":"Prostate cancer genetics: variation by race, ethnicity, and geography.","volume":"27","author":"Rebbeck","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"zoi200658r32","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.18632\/oncotarget.v8i5","article-title":"Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.","volume":"8","author":"Shiina","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"zoi200658r33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001387","article-title":"Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.","volume":"7","author":"Haiman","year":"2011","journal-title":"PLoS Genet"},{"issue":"2","key":"zoi200658r34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.juro.2016.08.104","article-title":"Racial disparities in active surveillance for prostate cancer.","volume":"197","author":"Krishna","year":"2017","journal-title":"J Urol"},{"issue":"5","key":"zoi200658r35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.eururo.2015.03.021","article-title":"Fifteen-year outcomes following conservative management among men aged 65 years or older with localized prostate cancer.","volume":"68","author":"Lu-Yao","year":"2015","journal-title":"Eur Urol"},{"issue":"21","key":"zoi200658r36","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1056\/NEJMc1900333","article-title":"Active surveillance for low-risk prostate cancer in black patients.","volume":"380","author":"Butler","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi200658r37","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.2105\/AJPH.94.12.2076","article-title":"Accounting for apparent \u201creverse\u201d racial disparities in Department of Veterans Affairs (VA)-based medical care: influence of out-of-VA care.","volume":"94","author":"Gurmankin","year":"2004","journal-title":"Am J Public Health"},{"issue":"9","key":"zoi200658r38","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/jgs.v67.9","article-title":"Low-value prostate cancer screening among older men within the veterans health administration.","volume":"67","author":"Radomski","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"zoi200658r39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11606-011-1945-9","article-title":"Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.","volume":"27","author":"So","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi200658r40","first-page":"67","article-title":"Active surveillance of prostate cancer.","volume":"31","author":"Choyke","year":"2017","journal-title":"Oncology (Williston Park)"},{"key":"zoi200658r14","unstructured":"The EQUATOR Network. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Accessed November 14, 2019. https:\/\/www.equator-network.org\/reporting-guidelines\/strobe\/"},{"key":"zoi200658r15","unstructured":"US Department of Veterans Affairs. Corporate Data Warehouse (CDW). Accessed November 14, 2019. https:\/\/www.hsrd.research.va.gov\/for_researchers\/vinci\/cdw.cfm"},{"key":"zoi200658r19","unstructured":"US Department of Veterans Affairs. VA priority groups. Published October 15, 2019. Accessed November 15, 2019. https:\/\/www.va.gov\/health-care\/eligibility\/priority-groups"},{"key":"zoi200658r24","unstructured":"University of Wisconsin School of Medicine Public Health. About the Neighborhood Atlas. Accessed June 25, 2020. https:\/\/www.neighborhoodatlas.medicine.wisc.edu\/"},{"key":"zoi200658r29","unstructured":"US Department of Veterans Affairs. Minority veterans report. Published March 2017. Accessed August 26, 2020. https:\/\/www.va.gov\/vetdata\/docs\/SpecialReports\/Minority_Veterans_Report.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2770879\/parikh_2020_oi_200658_1600201517.02878.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T15:34:51Z","timestamp":1601307291000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2770879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.18318","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]}}}